Akorn Obtains $675 Million of Loans for Hi-Tech Acquisition

Akorn Inc., a maker of generic eye-care products, obtained $675 million of financing commitments backing its purchase of Hi-Tech Pharmacal Co.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.